Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis
Schmidt CT, Deligiannidis KM, Kittel-Schneider S, Frodl T, Spigset O, Paulzen M, Schoretsanitis G (2022)
Publication Type: Journal article, Review article
Publication year: 2022
Journal
Book Volume: 124
Article Number: 110733
DOI: 10.1016/j.pnpbp.2023.110733
Abstract
Objective: Data on the ability of anticonvulsants and lithium to enter fetal and newborn circulation has become increasingly available; here we estimated penetration ratios in a series of matrices from combined samples of pregnant/breastfeeding women treated with anticonvulsants or lithium. Methods: We conducted a systematic literature search in PubMed/EMBASE for studies with concentrations of anticonvulsants/lithium from maternal blood, amniotic fluid, umbilical cord blood and/or breast milk. Penetration ratios were calculated by dividing the concentrations in amniotic fluid, umbilical cord plasma or breast milk by the maternal concentrations. When data from multiple studies were available, we calculated combined penetration ratios, weighting studies' mean by study size. Results: Ninety-one eligible studies for brivaracetam, carbamazepine, clonazepam, ethosuximide, gabapentin, lacosamide, lamotrigine, levetiracetam, lithium, oxcarbazepine, perampanel, phenobarbital, phenytoin, pregabalin, primidone, topiramate, valproate, vigabatrin and zonisamide were identified. For amniotic fluid, the highest penetration ratios were estimated for levetiracetam (mean 3.56, range 1.27–5.85, n = 2) and lowest for valproate (mean 0.11, range 0.02–1.02, n = 57). For umbilical cord plasma, oxcarbazepine had the highest ratio (mean 1.59, range 0.11–4.33, n = 12) with clonazepam having the lowest (mean 0.55, range 0.52–0.59, n = 2). For breast milk, the highest ratios were observed for oxcarbazepine (mean 3.75, range 0.5–7.0, n = 2), whereas the lowest were observed for valproate (mean 0.04, range 0.01–0.22, n = 121). Discussion: We observed substantial variability between anticonvulsants and lithium regarding their ability to enter fetal/newborn circulation. Assessing concentrations of anticonvulsants and lithium in maternal samples can provide a surrogate of fetal/infant exposure, although patterns of concentration-dependent effects for maternal/neonatal safety are lacking.
Involved external institutions
Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
Germany (DE)
Zucker Hillside Hospital
United States (USA) (US)
Universitätsklinikum Würzburg
Germany (DE)
St. Olavs University Hospital / St. Olavs Hospital Universitetssykehuset i Trondheim
Norway (NO)
Germany (DE)
Zucker Hillside Hospital
United States (USA) (US)
Universitätsklinikum Würzburg
Germany (DE)
St. Olavs University Hospital / St. Olavs Hospital Universitetssykehuset i Trondheim
Norway (NO)
How to cite
APA:
Schmidt, C.T., Deligiannidis, K.M., Kittel-Schneider, S., Frodl, T., Spigset, O., Paulzen, M., & Schoretsanitis, G. (2022). Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 124. https://doi.org/10.1016/j.pnpbp.2023.110733
MLA:
Schmidt, Chiara Theresa, et al. "Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis." Progress in Neuro-Psychopharmacology & Biological Psychiatry 124 (2022).
BibTeX: Download